Kvindelige patienter i den fødedygtige alder og deres partnere skal hver anvende en effektiv præventionsform under behandlingen og i 4 måneder efter behandlingen er ophørt.
Female patients of childbearing potential and their partners must each use an effective contraceptive during treatment and for 4 months after treatment has been concluded.